Sila Realty Trust, Inc.

Sila Realty Trust, Inc. (SILA) Market Cap

Sila Realty Trust, Inc. has a market capitalization of $1.41B.

Financials based on reported quarter end 2025-12-31

Price: $25.53

0.24 (0.95%)

Market Cap: 1.41B

NYSE · time unavailable

CEO: Michael A. Seton

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 2024-06-13

Website: https://silarealtytrust.com

Sila Realty Trust, Inc. (SILA) - Company Information

Market Cap: 1.41B · Sector: Real Estate

Sila Realty Trust, Inc. is a net lease real estate investment trust headquartered in Tampa, Florida, with a strategic focus on investing in the significant, growing, and resilient healthcare sector of the U.S. economy. The Company invests in high quality healthcare facilities along the continuum of care, which, we believe, generate predictable, durable, and growing income streams. Our portfolio is comprised of high quality tenants in geographically diverse facilities which are positioned to capitalize on the dynamic delivery of healthcare to patients. As of December 31, 2023, the Company owned 131 real estate properties and two undeveloped land parcels located in 62 markets across the United States.

Analyst Sentiment

73%
Strong Buy

Based on 5 ratings

Analyst 1Y Forecast: $26.50

Average target (based on 2 sources)

Consensus Price Target

Low

$25

Median

$27

High

$28

Average

$27

Potential Upside: 3.8%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 SILA RLTY TR INC TRUST (SILA) — Investment Overview

🧩 Business Model Overview

SILA Realty Trust, Inc. (SILA) is a real estate investment trust (REIT) focused primarily on acquiring, owning, and managing high-quality, mission-critical properties across the United States. With a particular emphasis on healthcare facilities and select industrial assets, SILA operates as a net-lease landlord. Its business model centers on acquiring properties staples to the operations of high-credit tenants, locking in long-term lease agreements indexed to inflation or stepped-rent increases. This model ensures a steady stream of income characterized by predictability, low tenant turnover, and lower capital expenditure requirements compared to more active property-owning peers. By targeting assets integral to tenants’ ongoing activities—such as medical outpatient facilities, specialty healthcare assets, and industrial/warehouse units—SILA’s portfolio aligns with sectors exhibiting favorable structural tailwinds. Additionally, SILA’s focus on investment-grade (or equivalent) tenants and strategic geographic diversification forms the backbone of its approach to generating sustainable income and capital appreciation for shareholders.

💰 Revenue Streams & Monetisation Model

SILA’s primary revenue is derived from leasing space to third-party tenants. This lease income, generally structured as triple-net (NNN) or double-net leases, passes through the majority of operational costs—such as maintenance, insurance, and taxes—to the tenant. As such, SILA enjoys a “bond-like” income stream with reduced volatility and overhead. The lease agreements typically offer built-in escalators, providing organic revenue growth over time. The company pursues two revenue-enhancing strategies: - **Property Acquisition:** SILA grows its rental income base by acquiring additional healthcare and industrial properties, focusing on assets underpinned by long-term leases to creditworthy operators. - **Lease Renewal/Restructuring:** Proactive asset management, including extending and renegotiating lease terms, allows SILA to adjust rents to current market values and lock in long-term tenancies, ensuring continued revenue sustainability. Secondary sources of income, such as parking, ancillary services, or reimbursements, are generally minor for SILA’s asset class but incrementally support its aggregate rental income.

🧠 Competitive Advantages & Market Positioning

A key pillar of SILA’s competitive advantage is its deep specialization in healthcare real estate—a sector marked by demographic-driven, inelastic demand. Healthcare facilities, particularly outpatient and specialized treatment centers, enjoy relatively stable occupancy and tenant credit profiles compared to traditional office or retail assets. This specialization provides a moat in the form of sector know-how, long-term relationships with healthcare operators, and an understanding of regulations and needs unique to medical real estate. SILA further differentiates itself through: - **Disciplined Acquisition:** The company maintains a rigorous underwriting process, emphasizing economic durability, tenant credit, and property location fundamentals. - **Leasing Structure:** Widespread use of net leases reduces exposure to expense volatility and property management overhead. - **Diversification:** By maintaining a geographically and tenant-diverse property mix, SILA mitigates risk from regional economic downturns or tenant-specific issues. - **Relationship Network:** Established relationships with healthcare providers and developers enable off-market sourcing and tailored deal structuring, supporting accretive acquisition activity. These factors position SILA as a stable, reliable player in the healthcare and industrial REIT space, with a defensible income base and resilience to economic cyclicality.

🚀 Multi-Year Growth Drivers

Several long-term trends support SILA’s growth prospects: - **Aging U.S. Population:** Growth in the elderly demographic drives increased healthcare consumption, necessitating expansion and modernization of medical real estate infrastructure. - **Shift to Outpatient Care:** Healthcare delivery continues to move away from costly hospital campuses toward outpatient and ambulatory centers. As these facilities proliferate, demand for purpose-built medical office and outpatient spaces—SILA’s specialty—remains robust. - **Resilient Tenant Demand:** Healthcare is an essential service less vulnerable to economic swings, supporting steady demand for SILA’s core properties. - **Scalable Acquisition Pipeline:** The highly fragmented U.S. healthcare real estate market enables SILA to continue rolling up individual assets or small portfolios, driving non-dilutive, rent-accretive growth. - **Institutionalization of Healthcare Real Estate:** As the sector continues to gain favor among institutional investors, cap rates compress and asset values rise, unlocking NAV growth opportunities for disciplined operators. For industrial assets, e-commerce expansion and ongoing supply chain reconfiguration similarly underpin robust leasing demand and rental rate growth.

⚠ Risk Factors to Monitor

Despite its defensive characteristics, the SILA investment thesis is not without risks: - **Tenant Concentration:** Dependence on a small number of large tenants or operator groups can expose the portfolio to cash flow interruptions should a significant lease terminate or encounter financial difficulty. - **Regulatory Dynamics:** Changes in health policy, reimbursement rates, or regulatory requirements may negatively impact the financial health of healthcare tenants, affecting their lease payment capacity. - **Interest Rate Sensitivity:** As a REIT, SILA’s valuation and dividend yield typically trade in relation to interest rates; material rises in rates can compress asset prices and raise financing costs. - **Acquisition Execution:** Growth depends on disciplined property acquisition at accretive yields—missteps could result in overpaying or integrating suboptimal assets. - **Limited Liquidity/Market Access:** Depending on public float or trading volume, investors may experience liquidity constraints or premium/discount swings to net asset value. Ongoing monitoring of tenant credit profile, portfolio diversification, and management’s acquisition discipline remain essential to mitigating these risk factors.

📊 Valuation & Market View

REITs like SILA are commonly valued using a combination of net asset value (NAV), adjusted funds from operations (AFFO) multiples, and dividend yield. Investors and analysts typically cross-reference these metrics with property cap rates and peer group valuations to assess relative value. SILA’s value proposition hinges on the durability and visibility of its net-leased cash flows, steady dividend payout, and potential for capital appreciation through both organic (rent growth, lease renewals) and inorganic (acquisitions, development) means. The company’s focus on healthcare and select industrial assets lends an attractive risk-adjusted yield, often commanding a premium to traditional office or retail REIT benchmarks. Market sentiment toward the healthcare sector—driven by secular demographic trends and inflation-hedged rental escalations—further supports a favorable view. Peer comparisons should consider the quality and longevity of SILA’s tenant roster, geographic and asset-class diversification, and balance sheet conservatism as core differentiators.

🔍 Investment Takeaway

SILA Realty Trust represents a compelling vehicle for investors seeking resilient, inflation-protected income streams via specialized exposure to the healthcare and industrial real estate sectors. Its disciplined acquisition approach, focus on net-leased properties, and prudent portfolio diversification underpin a stable and growing dividend profile. Long-term secular trends—ranging from the aging U.S. population to the continued evolution of outpatient care—provide multi-year growth opportunities, while exposure to essential infrastructure assets offers defensive qualities amid market volatility. However, prudent investors should monitor execution on acquisitions, tenant retention, and sector-specific regulatory shifts. SILA’s emphasis on healthcare real estate delivers a differentiated platform, balancing persistent income generation with potential for asset-level value appreciation over time.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"SILA reports revenue of $50.7M and net income of $5.015M, reflecting a positive performance trajectory in its financials. However, the company has not shown any operating cash flow, capital expenditure, or free cash flow in the latest report, indicating potential liquidity concerns. With total assets of $2.094B and total liabilities of $763.2M, SILA maintains a strong balance sheet with a healthy equity position of $1.331B. The company’s market price is $24, representing an 8.33% decline over the past year, despite dividends being consistently paid at $0.4 per share. The 1-year change in stock price suggests a shrinking shareholder value, negating much of the benefit from dividend distributions. Analyst sentiment appears muted with a price target consensus of $26.5, indicating limited growth expectation ahead. The lack of operating cash flow raises questions about the sustainability of its business model, necessitating close observation moving forward."

Revenue Growth

Neutral

Revenue of $50.7M shows moderate growth, but overall growth rate trends are not specified.

Profitability

Neutral

Net income of $5.015M indicates profitability, although margins need improvement.

Cash Flow Quality

Neutral

No operating or free cash flow reported, raising liquidity concerns.

Leverage & Balance Sheet

Good

Strong balance sheet with total equity of $1.331B relative to liabilities.

Shareholder Returns

Neutral

Market performance reflects a decline over one year, despite dividends.

Analyst Sentiment & Valuation

Fair

Price target indicates limited upside potential based on current performance.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

So what: Management is projecting a cautious growth posture anchored by liquidity (>$480M), leverage headroom (net debt/EBITDAre 3.9x vs 4.5x–5.5x target), and near-term NOI durability (EBITDARM coverage 5.9x, up from 5.3x). The tone is constructive in prepared remarks—portfolio credit quality rising (investment-grade guarantor/affiliate percentage 40.6%, +2.3% YoY) and development/expansion optionality. However, the Q&A reveals the real constraint: capital deployment cadence is explicitly “market-driven” and capped by competitive pricing, with repurchases treated cautiously due to institutionalization reducing market liquidity. Disposition mechanics also matter—Alexandria generated only $120k rent in Q4 via holdover (125% schedule through Nov) and some redevelopments may be “leased” in reporting before rent fully normalizes (free rent periods). Net: positive fundamentals, but AFFO drag (interest/swap dynamics) and disciplined underwriting/transaction timing keep growth from translating cleanly into per-share cash flow.

AI IconGrowth Catalysts

  • Purpose-built inpatient rehab facility in Oklahoma City (Nobis rehabilitation partners): expansion from 40 to 58 licensed beds; strong demand since opening
  • Redevelopment/existing-asset value creation: $7 million of redevelopment opportunities completed in 2025
  • In-place expansion opportunities via tenant demand within existing building envelopes (generally higher-yield than acquisitions: ~150–200 bps higher going-in cap rates)

Business Development

  • Nobis Rehabilitation Partners (long-term lease; Oklahoma City inpatient rehab; expanded bed count 40->58)
  • PAM Health (largest tenant; inpatient rehab leases; new lease amendments referenced for rent/FFO impacts; Dover and Overland Park facilities planned for additional capital investment)
  • Washington Regional Medical Center (investment-grade; executed lease and took occupancy of Fayetteville Healthcare facility from Community Health Systems)
  • Cencora (acquiring majority equity in OneOncology; becomes common control for 7 former GenesisCare master leased properties)
  • Tenor Health Foundation (acquired Community Health Systems Pennsylvania hospitals including Wilkes-Barre Healthcare facility effective Feb 1, 2026)
  • Select Medical (named as bankruptcy sale buyer for Savannah Healthcare tenant; Select becomes 4th largest tenant)

AI IconFinancial Highlights

  • FY2025 cash NOI: $169.9M vs $168.6M in FY2024 (+0.8%); same-store cash NOI growth 0.9%
  • Onetime items: 2024 benefited from $6M+ onetime lease termination/severance fees vs 2025 less than $0.3M; excluding onetime fees, cash NOI growth 4.4% and same-store cash NOI growth 1.1%
  • FFO per share FY2025: $2.16 (+3.6% YoY); AFFO per share FY2025: $2.18 (-5.8% YoY)
  • Portfolio-wide EBITDARM rent coverage FY2025: 5.9x vs 5.3x in FY2024; without sold Saginaw tenant, still 5.7x
  • Balance sheet: net debt/EBITDAre 3.9x vs targeted leverage range 4.5x–5.5x; total liquidity > $480M; debt $676M at weighted avg rate 4.7%
  • Q&A: Alexandria disposition rent timing—scheduled rent ~$40k/month; lease expired Aug; holdover paid through Nov at 125% of scheduled rent; total rent collected in Q4 $120k

AI IconCapital Funding

  • Debt/deployment capacity: remaining ability to reach 5.0x (midpoint) targeted leverage implies ~$225M of investing capacity; high end of 5.5x implies up to ~$375M
  • Liquidity/dry powder: total liquidity > $480M at year-end

AI IconStrategy & Ops

  • Demolition/carrying cost reduction at Stoughton Healthcare Facility: carrying costs reduced to ~ $35k/month from as much as $120k/month; demolition debris removal underway; expected finished by end of Q1 2026
  • Leasing outcomes: retained 90% of expiring tenancy on square-foot basis for 2025 scheduled expirations; expiring non-renewal only 0.5% of ABR; weighted average remaining lease term 9.7 years (end Q3) -> 10 years (year-end)
  • Planned 2026 dispositions/portfolio reshaping: sale of Saginaw Healthcare closed for gross proceeds $14.5M; Henderson and Las Vegas II estimated close in Q1 2026; Alexandria sale expected close end of Q1 / early Q2 2026 (vacant Dec 2025 after ASC tenant departure)

AI IconMarket Outlook

  • Leverage and buying power: to reach midpoint leverage 5x (from indicated 4.5x–5.5x range) investing about $225M; high end capacity up to $375M; cadence expected to be market-driven with about 24 months of buying capacity
  • Acquisition volume expectation: volume this year expected similar to last year; acquisition already completed this year; additional acquisitions could be more toward end of 2026 rather than beginning (per management focus on development opportunities with existing tenancy)

AI IconRisks & Headwinds

  • AFFO pressure: AFFO per share down 5.8% YoY driven primarily by higher interest expense (new swaps due to prior swap expirations) partially offset by cash NOI items
  • Competitive deal environment: management cited 'competition in the marketplace' and caution on acquisitions despite liquidity
  • Stock repurchase caution: management paused on repurchases because building institutional investor base 'pulls liquidity' out of the market (potential dilution/illiquidity concern)
  • Leasing/disposition timing risk: Alexandria income in Q4 impacted by holdover structure (lease expiry Aug but holdover through Nov), and redevelopment units may be considered leased at year-end while rent may begin after free rent periods (example: El Segundo with UCLA free rent period)

Sentiment: MIXED

Note: This summary was synthesized by AI from the SILA Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (SILA)

© 2026 Stock Market Info — Sila Realty Trust, Inc. (SILA) Financial Profile